Gene: SEMA4B
Official Full Name: semaphorin 4Bprovided by HGNC
Gene Summary: Predicted to enable chemorepellent activity; neuropilin binding activity; and semaphorin receptor binding activity. Predicted to be involved in several processes, including axon guidance; neural crest cell migration; and semaphorin-plexin signaling pathway. Predicted to be located in membrane and synapse. Predicted to be active in glutamatergic synapse and postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31779 | SEMA4B Knockout cell line (HeLa) | Human | SEMA4B | 1:3~1:6 | Negative | Online Inquiry |
KO31780 | SEMA4B Knockout cell line (HCT 116) | Human | SEMA4B | 1:2~1:4 | Negative | Online Inquiry |
KO31781 | SEMA4B Knockout cell line (HEK293) | Human | SEMA4B | 1:3~1:6 | Negative | Online Inquiry |
KO31782 | SEMA4B Knockout cell line (A549) | Human | SEMA4B | 1:3~1:4 | Negative | Online Inquiry |
SEMA4B Gene Knockout Cell Lines are genetically engineered cell lines in which the SEMA4B gene has been selectively inactivated, allowing researchers to investigate its biological roles more thoroughly. SEMA4B encodes a member of the semaphorin family, which are crucial for various physiological processes, including neuronal development and immune response modulation. The knockout mechanism typically employs CRISPR-Cas9 technology, creating precise deletions or mutations in the target gene, thereby enabling the comprehensive study of the gene's function in various biological contexts.
These cell lines facilitate the assessment of SEMA4B’s involvement in key pathways, particularly those related to cancer progression, neurodevelopmental disorders, and immune modulation. By studying these knockout models, scientists can elucidate the gene’s role in cellular signaling, migration, and differentiation, which are critical for understanding complex diseases. The ability to observe the phenotypic consequences of SEMA4B deletion allows researchers to provide insights that could inform therapeutic strategies.
One of the most significant advantages of SEMA4B Gene Knockout Cell Lines is their specificity and reproducibility compared to alternative gene manipulation methods, such as RNA interference, which may lead to off-target effects. This precision makes SEMA4B knockout cell lines invaluable for the development of bespoke cellular models that reflect human disease states with greater accuracy.
Moreover, the availability of these knockout lines significantly reduces the time and effort required for creating in-house models, allowing researchers to focus on their experiments and accelerate the pace of discovery in fields ranging from oncology to immunology.
Our company specializes in the development of high-quality biological product offerings, and our expertise in gene editing technologies ensures that researchers and clinicians can rely on our SEMA4B knockout cell lines to advance their investigations with confidence and clarity.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.